Re: HER2-Positive Breast Cancer: Beyond Trastuzumab
But...there seems to be value in continuing H after progression...with cancer stem cell implications. That's more than can be said for a lot of therapies.
I'm surprised they didn't get into the Her2/ER crosstalk issue.